Generics Top 5 Emerging Markets Industry Guide - Market Summary, Competitive Analysis and Forecast to 2025


Summary

The Emerging 5 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.


Key Highlights

  • These countries contributed $102,763.9 million to the global generics industry in 2020, with a compound annual growth rate (CAGR) of 8.1% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $145,054.2 million in 2025, with a CAGR of 7.1% over the 2020-25 period.
  • Within the generics industry, China is the leading country among the top 5 emerging nations, with market revenues of $74,954.1 million in 2020. This was followed by India and Mexico with a value of $15,736.1 and $6,202.9 million, respectively.
  • China is expected to lead the generics industry in the top five emerging nations, with a value of $103,911.3 million in 2025, followed by India and Mexico with expected values of $24,730.9 and $7,892.1 million, respectively.




Scope

  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five generics market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five generics market
  • Leading company profiles reveal details of key generics market players’ emerging five operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the emerging five generics market with five year forecasts by both value and volume
  • Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country




Reasons To Buy

  • What was the size of the emerging five generics market by value in 2020?
  • What will be the size of the emerging five generics market in 2025?
  • What factors are affecting the strength of competition in the emerging five generics market?
  • How has the market performed over the last five years?
  • How large is the emerging five generics market in relation to its regional counterparts?